Adenocarcinoma of the esophagogastric junction: For perioperative chemotherapy, against neoadjuvant radiotherapy

被引：0
作者：
Lordick F. [1 ]
机构：
[1] Medizinische Klinik I (Hämatologie, Zelltherapie, Internistische Onkologie, Hämostaseologie), Universitäres Krebszentrum Leipzig (UCCL), Universitätsklinikum Leipzig, Liebigstr. 22, Leipzig
来源：
Der Onkologe | 2019年 / 25卷 / 12期
关键词：
Combined modality therapy; Esophageal cancer; Gastric cancer; Metastasis; Perioperative care;
D O I：
10.1007/s00761-019-0635-9
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1046 / 1049
页数：3
相关论文
共 50 条
  • [1] Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy?
    Laxague, Francisco
    Schlottmann, Francisco
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (07):
  • [2] Benefit of Neoadjuvant Chemotherapy for Siewert Type II Esophagogastric Junction Adenocarcinoma
    Hosoda, Kei
    Yamashita, Keishi
    Katada, Natsuya
    Moriya, Hiromitsu
    Mieno, Hiroaki
    Sakuramoto, Shinichi
    Kikuchi, Shiro
    Watanabe, Masahiko
    ANTICANCER RESEARCH, 2015, 35 (01) : 419 - 425
  • [3] Gastric cancer and adenocarcinoma of the esophagogastric junction, Principles of neoadjuvant therapy
    Lordick, F.
    Ott, K.
    Sendler, A.
    CHIRURG, 2011, 82 (11): : 968 - 973
  • [4] Perioperative therapies in esophageal adenocarcinoma and cancer of the esophagogastric junction
    Scheck, Magdalena K.
    Lorenzen, Sylvie
    ONKOLOGIE, 2025, 31 (02): : 156 - 164
  • [5] Localized adenocarcinoma of the esophagogastric junction - Is there a standard of care?
    Power, D. G.
    Reynolds, J. V.
    CANCER TREATMENT REVIEWS, 2010, 36 (05) : 400 - 409
  • [6] Oxaliplatin in perioperative chemotherapy for gastric and gastroesophageal junction (GEJ) adenocarcinoma
    Fritsch, Ralph
    Hoeppner, Jens
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (04) : 285 - 291
  • [7] Neoadjuvant radiochemotherapy for esophagogastric junction adenocarcinomas
    Nikolaidou, Eirini
    Bostel, Tilman
    ONKOLOGIE, 2023, 29 (06): : 522 - 530
  • [8] Neoadjuvant docetaxel, oxaliplatin and S-1 (DOS) combination chemotherapy for patients with resectable adenocarcinoma of esophagogastric junction
    Saito, Takuro
    Kurokawa, Yukinori
    Takahashi, Tsuyoshi
    Yamamoto, Kazuyoshi
    Yamashita, Kotaro
    Tanaka, Koji
    Makino, Tomoki
    Nakajima, Kiyokazu
    Eguchi, Hidetoshi
    Doki, Yuichiro
    GASTRIC CANCER, 2022, 25 (05) : 966 - 972
  • [9] Neoadjuvant chemoradiation versus perioperative chemotherapy followed by surgery in resectable adenocarcinomas of the esophagogastric junction: A retrospective single center analysis
    Schulze, Bjoern
    Bergis, Dominik
    Balermpas, Panagiotis
    Trojan, Joerg
    Woeste, Guido
    Bechstein, Wolf Otto
    Roedel, Claus
    Weiss, Christian
    ONCOLOGY LETTERS, 2014, 7 (02) : 534 - 540
  • [10] Neoadjuvant chemoradiation versus perioperative chemotherapy for oeosphageal adenocarcinoma
    Reynolds, John, V
    BRITISH JOURNAL OF SURGERY, 2023, 110 (12) : 1681 - 1682
12345